2018 sees PrimeVigilance celebrate 10 Years of
delivering Pharmacovigilance and Medical Information
excellence to our customers around the globe.

PART 2 of EVDAS-related expectations from MAHs
UPDATE on the discussions taking place during pilot phase

14 June 2018 – 15.00 GMT, 16.00 CEST, 10.00 EDT
with Dr Cvijeta Bielen, Medical Director

With a proven track record in pharmacovigilance,
we also manage medical information queries,
adverse events and product quality complaints.

PrimeVigilance was founded in 2008
with now over 500 employees with offices
in the UK, US and Europe.

Our expertise and commercial vision
means you can rely on us to deliver high quality,
compliant and cost-effective solutions